BPG is committed to discovery and dissemination of knowledge
Featured Articles
3/15/2026 6:29:16 AM | Browse: 4 | Download: 13
Publication Name World Journal of Experimental Medicine
Manuscript ID 112270
Country Morocco
Received
2025-07-23 02:30
Peer-Review Started
2025-07-23 02:30
First Decision by Editorial Office Director
2025-08-01 09:33
Return for Revision
2025-08-01 09:33
Revised
2025-08-13 16:15
Publication Fee Transferred
Second Decision by Editor
2026-02-02 02:43
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-02-02 22:34
Articles in Press
2026-02-02 22:34
Edit the Manuscript by Language Editor
Typeset the Manuscript
2026-02-27 07:07
Publish the Manuscript Online
2026-03-15 06:19
ISSN 2220-315x (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Cardiac & Cardiovascular Systems
Manuscript Type Minireviews
Article Title Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs
Manuscript Source Invited Manuscript
All Author List Maha Bouziane, Omar Moufid and Rachida Habbal
Funding Agency and Grant Number
Corresponding Author Maha Bouziane, Assistant Professor, cardiology department, Ibn Rochd university Hospital of Casablanca, Corresponding author. Tel: 00212522482020/(P.269), Email: <email>mahabouziane@gmail.com</email>, Casablanca 20000, Casablanca-Settat, Morocco. mahabouziane@gmail.com
Key Words Cardiac amyloidosis; Light chains; Transthyretin; Diagnosis; Treatment
Core Tip This review highlights recent advances in cardiac amyloidosis (CA), a progressive infiltrative cardiomyopathy caused by amyloid fibril deposition in cardiac tissues. Improved recognition through advanced non-invasive imaging techniques and significant progress in disease-modifying therapies have transformed diagnosis and treatment. A multimodal diagnostic strategy and early identification are critical to improving patient outcomes. The review emphasizes the need for standardized diagnostic algorithms, increased clinical awareness, and a multidisciplinary approach to optimize care for patients with CA.
Publish Date 2026-03-15 06:19
Citation

Bouziane M, Moufid O, Habbal R. Cardiac amyloidosis: From diagnosis to therapeutics breakthroughs. World J Exp Med 2026; 16(1): 112270

URL https://www.wjgnet.com/2220-315x/full/v16/i1/112270.htm
DOI https://dx.doi.org/10.5493/wjem.v16.i1.112270
Full Article (PDF) WJEM-16-112270-with-cover.pdf
Manuscript File 112270_Auto_Edited_075422.docx
Answering Reviewers 112270-answering-reviewers.pdf
Audio Core Tip 112270-audio.m4a
Conflict-of-Interest Disclosure Form 112270-conflict-of-interest-statement.pdf
Copyright License Agreement 112270-copyright-assignment.pdf
Non-Native Speakers of English Editing Certificate 112270-non-native-speakers.pdf
Supplementary Material 112270-supplementary-material.pdf
Peer-review Report 112270-peer-reviews.pdf
Scientific Misconduct Check 112270-scientific-misconduct-check.png
Scientific Editor Work List 112270-scientific-editor-work-list.pdf
CrossCheck Report 112270-crosscheck-report.pdf